BACKGROUND Aspiration thrombectomy in ST-segment elevation myocardial infarction is recommended by current
However, in non-ST-segment elevation myocardial infarction (NSTEMI), w50% to 70% of all patients also display relevant thrombus burden in the culprit vessel (6) (7) (8) .
Furthermore, with rates of angiographic noreflow ranging from 15% to 40% depending on thrombus burden and intraprocedural thrombotic events, in a significant portion of patients with NSTEMI, only suboptimal reperfusion success can be achieved (9) (10) (11) Exclusion criteria were cardiogenic shock, STEMI, no identifiable culprit lesion, coronary morphology ineligible for thrombectomy (e.g., very tortuous vessels, severe calcification); indication for acute bypass surgery; age younger than 18 and older than 90 years; contraindications to treatment with heparin, aspirin, or thienopyridines; pregnancy; current participation in another clinical study; comorbidity with a limited life expectancy <6 months; and contraindications to CMR at study entry. All patients gave written informed consent before randomization. The lead ethical committee at the University of Leipzig and at all local ethical committees of the participating sites approved the study. For enzymatic infarct size determination, highsensitivity troponin T after 24 and 48 h was evaluated. A combined clinical endpoint of death, reinfarction, target vessel revascularization, and new congestive heart failure was assessed within 6 months of follow-up. The detailed definitions for the individual endpoints were published previously and reflect standard definitions (13, 15) . Clinical outcome at follow-up was assessed by a telephone interview. Thiele et al.
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Thrombus Aspiration in NSTEMI an absolute difference in MO of 0.5 AE 1.8%LV between the 2 treatment groups with a mean extent of 1.0%LV of late MO in the whole study cohort. This difference was judged clinically relevant (20) . On the basis of clinical experience and data on STEMI, it was further expected that thrombectomy could not be performed in 5% of all patients in the thrombectomy group and that as many as 10% of all patients would have no CMR data (19, 20) . This resulted in a total sample size of 2 Â 230 patients.
Pre-specified subgroup analyses by sex, the pres- 
RESULTS
Of the 460 patients initially scheduled for randomization, only 440 patients were ultimately enrolled.
Due to a technical error in the Internet-based randomization system, 20 data slots were erroneously marked as randomized patients. This was only discovered at the final database lock and analysis.
Given the unambiguous study results, the Steering Committee decided to close the study at 440 patients and not to randomize another 20 patients. Thus, 221
were randomly assigned to thrombectomy and 219 to standard PCI (Figure 1 ).
All patients received the assigned treatment, and thrombectomy was successfully performed in 217 patients (98%) in the thrombectomy group with macroscopic thrombus aspiration in 73%. There was Thrombus Aspiration in NSTEMI
no crossover in the standard PCI group. The baseline characteristics and medication were similar between groups with the exception of a higher rate of previous PCIs in the standard PCI group ( Table 1) . Procedural characteristics and in-hospital medication also were similar between groups. However, in the thrombectomy group, significantly more patients underwent primary stenting without pre-dilation of the lesion (p < 0.001) ( Table 1) .
CMR IMAGING. Results of CMR imaging were available in 181 (82%) of the thrombectomy group and in 192 (88%) of the standard PCI group (Figure 1) . Figure 1 . Table 2 ).
Reasons for not undergoing CMR are listed in
There was also no effect of thrombectomy in the pre- Thiele et al.
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DISCUSSION
The main results of this first randomized multicenter trial assessing aspiration thrombectomy in patients with NSTEMI with thrombus-containing lesions in the infarct-related artery can be summarized as follows. Aspiration thrombectomy led to aspiration of macroscopic thrombus material in 75% of patients, which resulted in a significantly higher rate of primary stent implantation without pre-dilation in the thrombectomy group compared with the standard PCI arm. However, aspiration thrombectomy did not reduce the extent of MO compared with standard PCI without thrombectomy, which is corroborated by a lack of benefit in secondary endpoints.
In patients with STEMI, the pivotal TAPAS 24-27 ). However, it also has been shown that single or multicenter study design had a significant impact on outcomes in these trials, and the major effect was driven by the single-center TAPAS trial. Nevertheless, based on these data, current American and European guidelines suggest performing manual aspiration thrombectomy in STEMI with a Class IIa Level of Evidence: B recommendation (4, 5) . These guideline recommendations were recently challenged by the largest randomized trial so far, which did not show a mortality benefit with routine aspiration thrombectomy (28) .
Another large-scale trial assessing the effects of routine thrombus aspiration on clinically important endpoints is currently ongoing (29) .
In the majority of both STEMI and NSTEMI patients, the key pathophysiological substrate is rupture of a vulnerable plaque with subsequent coronary thrombosis (Central Illustration). Whereas in STEMI, the thrombus is mostly fibrin rich leading to total vessel occlusion, the thrombus in many patients with NSTEMI is predominantly platelet rich and unstable, leading to only partial or intermittent occlusion of the coronary vessel (12) . Despite these pathophysiological considerations, the majority of patients with NSTEMI demonstrate relevant thrombus burden or even occluded coronary arteries and thus might benefit from thrombectomy (6, 8, 11 ). Nevertheless, current guidelines do not recommend thrombus aspiration in NSTEMI patients (12, 30) . This is mainly due to the lack of data in NSTEMI patients with only 1 published prospective observational study so far (7) . In this observational study that included 70 NSTEMI patients, thrombus was detected in w50% on the initial angiogram. Manual thrombus aspiration was associated with a significant reduction of the TIMI thrombus score and an increase in the rate of TIMI flow grade 3.
After thrombus aspiration, direct stenting without pre-dilation was possible in 56% of patients (7), which is slightly lower than in our trial. Trials in STEMI patients also show heterogeneous direct stenting rates ranging from 21% to 92% (26) . Thiele et al.
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